SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.

News Shandong Sinobioway Biomedicine Co., Ltd.

Equities

002581

CNE1000012Y5

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
12.49 ^CNY	+0.81%		-6.44%	-14.45%

Apr. 29	Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 29	Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
Sinobioway Biomedicine's Unit to Relocate	Dec. 12	MT
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Shandong Sinobioway Biomedicine Co., Ltd.(XSEC:002581) added to S&P Global BMI Index	23-09-18	CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Sinobioway Biomedicine Taps Builders for Planned Industrial Park	23-08-17	MT
Sinobioway Biomedicine Earmarks 1 Billion Yuan for Pharmaceutical Industrial Park	23-04-27	MT
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Shandong Sinobioway Biomedicine Co., Ltd. Announces Executive Appointments	22-08-23	CI
Shenzhen Yilian Technology Limited Company and Shenzhen Jialian Private Equity Investment Fund Management Co., Ltd. won the auction to acquire 8.67% stake in Shandong Sinobioway Biomedicine Co., Ltd. from Beijing Sinobioway Group Co., Ltd. for CNY 77.85 million.	22-06-01	CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Xiamen Hengxing Group Co., Ltd. acquired Shandong Sinobioway Biomedicine Co., Ltd. from Shenzhen Sandao Investment Management Enterprise (Limited Partnership) for CNY 200 million.	21-09-17	CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-30	CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Shandong Sinobioway Biomedicine Co., Ltd.

Equities

002581

CNE1000012Y5

Summary

Filters